Varaico: Literature-Extracted Genetic Variants

Gene:PTPN11
Variant:p.R498W
Back to variants list

PTPN11

NM_002834.5:p.R498W

Associated Papers

Clinical Spectrum of Noonan Syndrome-Associated Myeloproliferative Disorder.

Hirabayashi S et al.

American Journal of Hematology, 2026

Prenatal Diagnosis of Malformations of Cortical Development: A Review of Genetic and Imaging Advances.

Hu J et al.

Biomedicines, 2026

41595643 (PubMed )
Supplement: biomedicines-14-00107-s001.zip › Supplementary_File_S1.xlsx › Data_Extraction

PTPN11 mutations define a rare but highly adverse subset of myelodysplastic syndromes.

Bazinet A et al.

Haematologica, 2025

Understanding Molecular Basis of PTPN11-Related Diseases.

Um S et al.

Arxiv, 2025

41479460 (PubMed )
Supplement: NIHPP2511.11860v1-supplement-1.pdf

Clinical and molecular analysis of seventy-one fetal cases with RASopathies.

Yu QX et al.

European Journal of Obstetrics, Gynecology, and Reproductive Biology, 2025

Deep mutational scanning of the multi-domain phosphatase SHP2 reveals mechanisms of regulation and pathogenicity.

Jiang Z et al.

Nature Communications, 2025

40595497 (PubMed )
Supplement: 41467_2025_60641_MOESM5_ESM.xlsx › ClinVar_annotated

Prenatal Exome Sequencing for Fetal Macrocephaly: A Large Prospective Observational Cohort Study.

Zhou H et al.

Prenatal Diagnosis, 2025

Gene signatures and genotype-phenotype correlations of sensorineural hearing loss in Noonan syndrome and related RASopathies.

Lee SJ et al.

Scientific Reports, 2025

Advancing Non-Invasive Prenatal Screening: A Targeted 1069-Gene Panel for Comprehensive Detection of Monogenic Disorders and Copy Number Variations.

Sirica R et al.

Genes, 2025

Genomic analysis of 11,555 probands identifies 60 dominant congenital heart disease genes.

Sierant MC et al.

Proceedings of the National Academy of Sciences of the United States of America, 2025

40127276 (PubMed )
Supplement: pnas.2420343122.sapp.pdf

Integrating molecular analyses with the 2021 WHO classification of adult pilocytic astrocytomas.

Moreno-Torres B et al.

Journal of Neuropathology and Experimental Neurology, 2025

Longitudinal multimodal profiling of IDH-wildtype glioblastoma reveals the molecular evolution and cellular phenotypes underlying prognostically different treatment responses.

Lucas CG et al.

Neuro-oncology, 2025

39560080 (PubMed )
Supplement: noae214_suppl_supplementary_tables.xlsx › Table_S5

Genetic diagnostic outcomes from a 10-year research programme in autism in Aotearoa New Zealand.

Musgrave SM et al.

Journal of the Royal Society of New Zealand, 2025

40756852 (PubMed )
Supplement: TNZR_A_2394128_SM9470.xlsx › Sheet1

Clinical features and molecular genetics of patients with RASopathies: expanding the phenotype with rare genes and novel variants.

Yılmaz Uzman C et al.

European Journal of Pediatrics, 2024

Deep mutational scanning of a multi-domain signaling protein reveals mechanisms of regulation and pathogenicity.

Jiang Z et al.

Biorxiv : the Preprint Server for Biology, 2024

39091798 (PubMed )
Supplement: media-6.xlsx › ClinVar_annotated

Benchmarking nanopore sequencing and rapid genomics feasibility: validation at a quaternary hospital in New Zealand.

Nyaga DM et al.

Npj Genomic Medicine, 2024

Variants of the PTPN11 Gene in Mexican Patients with Noonan Syndrome.

Zepeda-Olmos PM et al.

Genes, 2024

Genomic ascertainment to quantify prevalence and cancer risk in adults with pathogenic and likely pathogenic germline variants in RASopathy genes.

Kim J et al.

Medrxiv : the Preprint Server for Health Sciences, 2024

39802765 (PubMed )
Supplement: media-1.xlsx › Supplementary_Table_1

Genetic basis of osteogenesis imperfecta from a single tertiary centre in South Africa.

Coetzer KC et al.

European Journal of Human Genetics : Ejhg, 2024

ASXL1 inactivation and reduced H3K27me3 across central nervous system tumors.

Zhang KY et al.

Acta Neuropathologica, 2024

39141113 (PubMed )
Supplement: 401_2024_2785_MOESM2_ESM.xlsx › STab2

Multi-scale signaling and tumor evolution in high-grade gliomas.

Liu J et al.

Cancer Cell, 2024

Novel Multiplexed Plasma Biomarker Panel Has Diagnostic and Prognostic Potential in Children With Hypertrophic Cardiomyopathy.

Captur G et al.

Circulation. Genomic and Precision Medicine, 2024

38847081 (PubMed )
Supplement: hcg-17-e004448-s001.pdf

Relationship Between Genotype Status and Clinical Outcome in Hypertrophic Cardiomyopathy.

Bonaventura J et al.

Journal of the American Heart Association, 2024

38757491 (PubMed )
Supplement: JAH3-13-e033565-s001.pdf

MEK Inhibition for RASopathy-Associated Hypertrophic Cardiomyopathy: Clinical Application of a Basic Concept.

Chaput D et al.

The Canadian Journal of Cardiology, 2024

[Translated article] Noonan Syndrome With Multiple Lentigines.

Martinez-Molina M et al.

Actas Dermo-sifiliograficas, 2024

Paternally Inherited Noonan Syndrome Caused by a PTPN11 Variant May Exhibit Mild Symptoms: A Case Report and Literature Review.

Han JY et al.

Genes, 2024

Spectrum of Mutations in PTPN11 in Russian Cohort.

Orlova A et al.

Genes, 2024

Exome Sequencing Identifies Multiple Genetic Diagnoses in Children with Syndromic Growth Disorders.

Rezende RC et al.

The Journal of Pediatrics, 2024

Beyond Single Diagnosis: Exploring Multidiagnostic Realities in Pediatric Patients through Genome Sequencing.

Guo F et al.

Human Mutation, 2024

PTPN11 variant may be a prognostic indicator of IDH-wildtype glioblastoma in a comprehensive genomic profiling cohort.

Otani R et al.

Journal of Neuro-oncology, 2023

Genotypic Findings in Noonan and Non-Noonan RASopathies and Patient Eligibility for Growth Hormone Treatment.

Carcavilla A et al.

Journal of Clinical Medicine, 2023

37568403 (PubMed )
Supplement: jcm-12-05003-s001.zip › jcm-2490499-supplementary.pdf

Genomic analysis of plasma circulating tumor DNA in patients with heavily pretreated HER2 + metastatic breast cancer.

Lee K et al.

Scientific Reports, 2023

37336919 (PubMed )
Supplement: 41598_2023_35925_MOESM1_ESM.xlsx › Table_S4__patho_variants_

FMRP activity and control of Csw/SHP2 translation regulate MAPK-dependent synaptic transmission.

Leahy SN et al.

Plos Biology, 2023

Publicly funded exome sequencing for outpatients with neurodevelopmental disorders demonstrates a high rate of unexpected findings impacting medical management.

Nakhleh Francis Y et al.

Genetics in Medicine Open, 2023

Lymphatic anomalies during lifetime in patients with Noonan syndrome: Retrospective cohort study.

Swarts JW et al.

American Journal of Medical Genetics. Part A, 2022

Circulating tumor DNA sequencing provides comprehensive mutation profiling for pediatric central nervous system tumors.

Bonner ER et al.

Npj Precision Oncology, 2022

36068285 (PubMed )
Supplement: 41698_2022_306_MOESM3_ESM.xlsx › 3.846CSF_Complete_Output

Molecular landscape of TP53 mutations in breast cancer and their utility for predicting the response to HER-targeted therapy in HER2 amplification-positive and HER2 mutation-positive amplification-negative patients.

Liu B et al.

Cancer Medicine, 2022

35393784 (PubMed )
Supplement: CAM4-11-2767-s001.xlsx › Table_S2

Clinical characteristics and survival of children with hypertrophic cardiomyopathy in China: A multicentre retrospective cohort study.

Chan W et al.

Eclinicalmedicine, 2022

35747179 (PubMed )
Supplement: mmc1.pdf

Craniosynostosis is a feature of Costello syndrome.

Weaver KN et al.

American Journal of Medical Genetics. Part A, 2022

Case report: Chronic lymphocytic leukemia/small lymphocytic lymphoma and monomorphic epitheliotropic intestinal T-cell lymphoma: A composite lymphoma.

Zhang B et al.

Pathology Oncology Research : Por, 2022

Discordance of PIK3CA and TP53 mutations between breast cancer brain metastases and matched primary tumors.

Thulin A et al.

Scientific Reports, 2021

34876602 (PubMed )
Supplement: 41598_2021_2903_MOESM1_ESM.xlsx › Blad1

Application of CRISPR-Cas9 gene editing for congenital heart disease.

Seok H et al.

Clinical and Experimental Pediatrics, 2021

Drosophila RASopathy models identify disease subtype differences and biomarkers of drug efficacy.

Das TK et al.

Iscience, 2021

1–50 of 104 papers
Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."